Medacta Group S.A. (0A05) Q4 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Medacta Group Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.598 Good afternoon, this is the Coral School Conference Operator. 00:00:02.598 -- 00:00:07.954 Welcome and thank you for joining the Medacta Group Full Year 2024 Results 00:00:07.954 -- 00:00:12.805 Conference Call. As a reminder, all participants are in listen-only mode. 00:00:12.805 -- 00:00:16.770 After the presentation, there will be an opportunity to ask questions. 00:00:16.770 -- 00:00:20.754 Should anyone need assistance during the conference call, they may signal an operator 00:00:20.754 -- 00:00:24.178 by pressing star and zero on their telephone. 00:00:24.178 -- 00:00:27.282 At this time, I would like to turn the conference over to Mr. 00:00:27.282 -- 00:00:33.707 Francesco Siccardi, CEO of Medacta Group. Please go ahead, sir. 00:00:34.470 -- 00:00:39.716 Thank you, and good afternoon, everybody. Welcome to Medacta 00:00:39.716 -- 00:00:45.062 2024 full year results. I am here with Corrado 00:00:45.062 -- 00:00:50.469 Forsetta, MD, CFO, and we will guide you through the 00:00:50.469 -- 00:00:54.414 presentation we released this morning. 00:00:54.414 -- 00:00:59.818 First of all, let's just remember our disclaimers. 00:01:00.061 -- 00:01:03.825 So the highlights of 2024 00:01:03.825 -- 00:01:05.868 started with our 00:01:05.868 -- 00:01:11.047 revenue release that we already published A few weeks ago, a 00:01:11.047 -- 00:01:16.647 very good growth, over 16% in cost and currency, 00:01:16.647 -- 00:01:20.322 surpassing €590 million. 00:01:20.322 -- 00:01:26.090 And this is combined with a good, excellent profitability 00:01:26.090 -- 00:01:28.834 with a 28% EBDA 00:01:28.834 -- 00:01:32.900 margin in cost and currency or 27.1 00:01:32.900 -- 00:01:39.607 in euro, a good increase of 19.4% over 2023. 00:01:41.467 -- 00:01:46.718...